The project will compress what is typically 10 years of vaccine development and testing into a matter of months, testimony to the urgency to halt a pandemic that has infected more than 5 million people, killed over 335,000 and battered economies worldwide.
According to the survey, conducted by YouGov and Yahoo News, 55% of Americans said they will get vaccinated for the virus "if and when a coronavirus vaccine becomes available".
The majority of the polls' responders said they agree that "vaccines for diseases such as measles are safe for both adults and children".
Among those respondents who expressed little or no interest in a coronavirus vaccine, almost half said they were anxious about the speed with which they are being developed.
Jeff Douglas, the managing director of Douglas Pharmaceuticals, will chair the company Covid-19 Vaccine Corporation Limited.
While these breakthroughs have been significant, no vaccine is ready for publid deployment yet, and it will likely be some time before one is. The poll found that a quarter of Americans have little or no interest in being vaccinated against coronavirus.
Most of the survey's pollsters said they would be "heavily influenced by guidance from the Food and Drug Administration [FDA]".
Liverpool School of Tropical Medicine has begun recruiting frontline health and social care workers to take part in a COVID-19 vaccine trial.
Experts believe the pollsters who are on the fence about whether or not they would take a vaccine could probably be persuaded.
Less than two-thirds of respondents said they were "very" or "somewhat" interested in a vaccine, a figure some health experts expected would be higher given the heightened awareness of COVID-19 and the more than 92,000 coronavirus-related deaths in the United States alone. "I would have expected somewhere around 75 percent".